~(131)Ⅰ治疗甲状腺功能亢进(甲亢)的主要并发症是甲状腺功能减低(甲低)。1985～1987年我们对治疗后的有关激素变化进行追踪研究,提出了最佳随访时间及监测指标,并改进~(131)Ⅰ治疗方法,从而减少了甲低的发生。一、资料与方法1.对象:用~(131)治疗甲亢122例,随访复查项目完整者101例。其中女74例,男27例,年龄25 The main complication of ~ (131) Ⅰ in the treatment of hyperthyroidism (Hyperthyroidism) is hypothyroidism (hypothyroidism). From 1985 to 1987, we tracked the relevant hormonal changes after treatment, proposed the best follow-up time and monitoring indicators, and improved 131I treatment, thus reducing the incidence of hypothyroidism. First, the data and methods 1 object: ~ (131) treatment of 122 cases of hyperthyroidism, follow-up review of 101 cases of the complete project. 74 were female and 27 were male, with an age of 25